Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans
Immunity · 2024-04 · 57 (4) · 904-911.e4
DOI: 10.1016/j.immuni.2024.02.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, 2024-04. Verfasst von M Alejandra Tortorici und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Washington, Seattle, WA 98195, USA. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 132-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, Howard Hughes Medical Institute.
Abstract (Originalsprache)
Immune imprinting describes how the first exposure to a virus shapes immunological outcomes of subsequent exposures to antigenically related strains. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Omicron breakthrough infections and bivalent COVID-19 vaccination primarily recall cross-reactive memory B cells induced by prior Wuhan-Hu-1 spike mRNA vaccination rather than priming Omicron-specific naive B cells. These findings indicate that immune imprinting occurs after repeated Wuhan-Hu-1 spike exposures, but whether it can be overcome remains unclear. To understand the persistence of immune imprinting, we investigated memory and plasma antibody responses after administration of the updated XBB.1.5 COVID-19 mRNA vaccine booster. We showed that the XBB.1.5 booster elicited neutralizing antibody responses against current variants that were dominated by recall of pre-existing memory B cells previously induced by the Wuhan-Hu-1 spike. Therefore, immune imprinting persists after multiple exposures to Omicron spikes through vaccination and infection, including post XBB.1.5 booster vaccination, which will need to be considered to guide future vaccination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.
- Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA.
- Department of Biochemistry, University of Washington, Seattle, WA 98195, USA; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA. Electronic address: dveesler@uw.edu.
Förderung
- NIH HHS
- NIAID NIH HHS
- Howard Hughes Medical Institute
- Wellcome Trust
- HHMI
Zitieren
APA
Tortorici, M. A., Addetia, A., Seo, A. J., Brown, J., Sprouse, K., Logue, J., Clark, E., Franko, N., Chu, H., & Veesler, D. (2024). Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans. Immunity, 57(4), 904-911.e4. https://doi.org/10.1016/j.immuni.2024.02.016
Vancouver
Tortorici MA, Addetia A, Seo AJ, Brown J, Sprouse K, Logue J, et al. Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans. Immunity. 2024;57(4):904-911.e4. doi:10.1016/j.immuni.2024.02.016
BibTeX
@article{Tortorici2024,
author = {Tortorici, M Alejandra and Addetia, Amin and Seo, Albert J and Brown, Jack and Sprouse, Kaiti and Logue, Jenni and Clark, Erica and Franko, Nicholas and Chu, Helen and Veesler, David},
title = {Persistent immune imprinting occurs after vaccination with the COVID-19 XBB.1.5 mRNA booster in humans},
journal = {Immunity},
year = {2024},
volume = {57},
number = {4},
pages = {904--911.e4},
doi = {10.1016/j.immuni.2024.02.016}
}
EUVIMED